ΔΙΑΒΗΤΟΛΟΓΙΚΟ ΤΜΗΜΑ – ΔΗΜΟΣΙΕΥΣΕΙΣ (2015-2018)
Grigoropoulou P, Tentolouris A, Eleftheriadou I, Tsilingiris D, Vlachopoulos C, Sykara M, Tentolouris N. Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia. Diab Vasc Dis Res. 2018 Oct 17:1479164118805320. doi: 10.1177/1479164118805320.
Karageorgiou V, Papaioannou TG, Bellos I, Alexandraki K, Tentolouris N, Stefanadis C, Chrousos GP, Tousoulis D. Effectiveness of artificial pancreas in the non-adult population: a systematic review and network meta-analysis. Metabolism. 2018 Oct 12. pii: S0026-0495(18)30212-9.
Paschou SA, Stamou M, Vuagnat H, Tentolouris N, Jude E. Pain management of chronic wounds: Diabetic ulcers and beyond. Maturitas. 2018 Nov; 117:17-21. doi: 10.1016/j.maturitas.2018.08.013.
Hernandez AF, Green JB, Janmohamed S, D’Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. Lancet. 2018 Oct 1. pii: S0140-6736(18)32261-X. doi: 10.1016/S0140-6736(18)32261-X.
Tentolouris A, Eleftheriadou I, Tsilingiris D, Anastasiou IA, Kosta OA, Mourouzis I, Kokkinos A, Pantos C, Katsilambros N, Tentolouris N. Plasma Irisin Levels in Subjects with Type 1 Diabetes: Comparison with Healthy Controls. Horm Metab Res. 2018 Oct 4. doi: 10.1055/a-0748-6170.
Liakos A, Lambadiari V, Bargiota A, Kitsios K, Avramidis I, Kotsa K, Gerou S, Boura P, Tentolouris N, Dimitriadis G, Tsapas A. Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab. 2018 Sep 22. doi: 10.1111/dom.13541.
Mamakou V, Hackinger S, Zengini E, Tsompanaki E, Marouli E, Serafetinidis I, Prins B, Karabela A, Glezou E, Southam L, Rayner NW, Kuchenbaecker K, Lamnissou K, Kontaxakis V, Dedoussis G, Gonidakis F, Thanopoulou A, Tentolouris N, Zeggini E. Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study. BMC Psychiatry. 2018 Aug 2;18(1):249. doi: 10.1186/s12888-018-1826-4.
Nikoloudi M, Eleftheriadou I, Tentolouris A, Kosta OA, Tentolouris N. Diabetic Foot Infections: Update on Management. Curr Infect Dis Rep. 2018 Aug 1;20(10):40. doi: 10.1007/s11908-018-0645-6.
Argyrakopoulou G, Kontrafouri P, Eleftheriadou I, Kokkinos A, Arapostathi C, Kyriaki D, Perrea D, Revenas C, Katsilambros N, Tentolouris N. The Effect of the Oral Administration of Leucine on Endothelial Function, Glucose and Insulin Concentrations in Healthy Subjects. Exp Clin Endocrinol Diabetes. 2018 Jun 11. doi: 10.1055/a-0597-8985.
Eleftheriadou I, Drosos GC, Tentolouris A, George K, Sfikakis PP, Protogerou AD, Tentolouris N. Pulse pressure amplification and cardiac autonomic dysfunction in patients with type 2 diabetes mellitus. J Hum Hypertens. 2018 Sep;32(8-9):531-539. doi: 10.1038/s41371-018-0070-1.
Tentolouris A, Eleftheriadou I, Athanasakis K, Kyriopoulos J, Tsilimigras DI, Grigoropoulou P, Doupis J, Tentolouris N. Prevalence of diabetes mellitus as well as cardiac and other main comorbidities in a representative sample of the adult Greek population in comparison with the general population. Hellenic J Cardiol. 2018 May 3. pii: S1109-9666(18)30038-1. doi: 10.1016/j.hjc.2018.04.008.
Pavlou DI, Paschou SA, Anagnostis P, Spartalis M, Spartalis E, Vryonidou A, Tentolouris N, Siasos G. Hypertension in patients with type 2 diabetes mellitus: Targets and management. Maturitas. 2018 Jun;112:71-77. doi: 10.1016/j.maturitas.2018.03.013.
Tentolouris A, Eleftheriadou I, Tentolouris N. Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes. Ann Transl Med. 2018 Feb;6(3):63. doi: 10.21037/atm.2017.12.28.
Agathos E, Tentolouris A, Eleftheriadou I, Katsaouni P, Nemtzas I, Petrou A, Papanikolaou C, Tentolouris N. Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy. J Int Med Res. 2018 May;46(5):1779-1790. doi: 10.1177/0300060518756540.
Tsiompanidis E, Siakavellas SI, Tentolouris A, Eleftheriadou I, Chorepsima S, Manolakis A, Oikonomou K, Tentolouris N. Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity. World J Gastrointest Pathophysiol. 2018 Feb 15;9(1):28-36.
Billings LK, Doshi A, Gouet D, Oviedo A, Rodbard HW, Tentolouris N, Grøn R, Halladin N, Jodar E. Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial. Diabetes Care. 2018 May;41(5):1009-1016. doi: 10.2337/dc17-1114.
Bistola V, Lambadiari V, Dimitriadis G, Ioannidis I, Makrilakis K, Tentolouris N, Tsapas A, Parissis J. Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors. Heart Fail Rev. 2018 May;23(3):377-388. doi: 10.1007/s10741-018-9674-3.
Kollia C, Antonopoulos AS, Siasos G, Konsola T, Oikonomou E, Gouliopoulos N, Tsigkou V, Papapanagiotou A, Kassi E, Tentolouris N, Katsiki N, Vavuranakis M, Papavassiliou AG, Tousoulis D. Associations between adiponectin gene variability, pro-inflammatory and angiogenetic markers: implications for microvascular disease development in type 2 diabetes mellitus? Curr Vasc Pharmacol. 2018 Jan 7. doi: 10.2174/1570161116666180108113825.
Makariou SE, Elisaf M, Challa A, Tentolouris N, Liberopoulos EN. No effect of vitamin D supplementation on cardiovascular risk factors in subjects with metabolic syndrome: a pilot randomised study. Arch Med Sci Atheroscler Dis. 2017 Oct 5;2:e52-e60. doi: 10.5114/amsad.2017.70504.
Kanellos PT, Kaliora AC, Protogerou AD, Tentolouris N, Perrea DN, Karathanos VT. The effect of raisins on biomarkers of endothelial function and oxidant damage; an open-label and randomized controlled intervention. Food Res Int. 2017 Dec;102:674-680. doi: 10.1016/j.foodres.2017.09.061
Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Tektonidou MG. Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study. Semin Arthritis Rheum. 2018 Jun;47(6):883-889. doi: 10.1016/j.semarthrit.2017.10.015.
Doulgerakis D, Moyssakis I, Kapelios CJ, Eleftheriadou I, Chorepsima S, Michail S, Tentolouris N. Cardiac Autonomic Neuropathy Predicts All-Cause and Cardiovascular Mortality in Patients With End-Stage Renal Failure: A 5-Year Prospective Study. Kidney Int Rep. 2017 Mar 16;2(4):686-694. doi: 10.1016/j.ekir.2017.03.002.
Marouli E, Kanoni S, Mamakou V, Hackinger S, Southam L, Prins B, Rentari A, Dimitriou M, Zengini E, Gonidakis F, Kolovou G, Kontaxakis V, Rallidis L, Tentolouris N, Thanopoulou A, Lamnissou K, Dedoussis G, Zeggini E, Deloukas P. Evaluating the glucose raising effect of established loci via a genetic risk score. PLoS One. 2017 Nov 10;12(11):e0186669. doi: 10.1371/journal.pone.0186669.
Siegmund T, Tentolouris N, Knudsen ST, Lapolla A, Prager R, Phan TM, Wolden ML, Schultes B; EU-TREAT study group. A European, multicentre, retrospective, non-interventional study (EU-TREAT) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetes. Diabetes Obes Metab. 2018 Mar;20(3):689-697. doi: 10.1111/dom.
Mamakou V, Eleftheriadou I, Katsiki N, Makrilakis K, Tsioufis K, Tentolouris N. Antidiabetic Drugs as Antihypertensives: New Data on the Horizon. Curr Vasc Pharmacol. 2017;16(1):70-78. doi: 10.2174/1570161115666171010122332.
Cnop M, Klupa T, Tentolouris N, Novials A, Burcelin R, van Eimeren M. Europe has to step up its efforts to produce innovative and safe diabetes technology. Diabetologia. 2017 Dec;60(12):2532-2533. doi: 10.1007/s00125-017-4455-4.
Tentolouris A, Eleftheriadou I, Grigoropoulou P, Kokkinos A, Siasos G, Ntanasis-Stathopoulos I, Tentolouris N. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complications. 2017 Nov;31(11):1624-1629.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Liraglutide and Renal Outcomes in Type 2 Diabetes. N Engl J Med. 2017 Aug 31;377(9):839-848.
Antonopoulos S, Mylonopoulou M, Angelidi AM, Kousoulis AA, Tentolouris N. Association of matrix γ-carboxyglutamic acid protein levels with insulin resistance and Lp(a) in diabetes: A cross-sectional study. Diabetes Res Clin Pract. 2017 Aug;130:252-257.
Tentolouris N, Kanellos PT, Siami E, Athanasopoulou E, Chaviaras N, Kolovou G, Sfikakis PP, Katsilambros N. Assessment of the Validity and Reproducibility of a Novel Standardized Test Meal for the Study of Postprandial Triacylglycerol Concentrations. Lipids. 2017 Aug;52(8):675-686.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. N Engl J Med. 2017 Aug 24;377(8):723-732.
Eleftheriadou I, Grigoropoulou P, Liberopoulos E, Liatis S, Kokkinos A, Tentolouris N. Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications. Curr Med Chem. 2018;25(13):1549-1566.
Chorepsima S, Eleftheriadou I, Tentolouris A, Moyssakis I, Protogerou A, Kokkinos A, Sfikakis PP, Tentolouris N. Pulse wave velocity and cardiac autonomic function in type 2 diabetes mellitus. BMC Endocr Disord. 2017 May 19;17(1):27. doi: 10.1186/s12902-017-0178-2.
Grigoropoulou P, Eleftheriadou I, Jude EB, Tentolouris N. Diabetic Foot Infections: an Update in Diagnosis and Management. Curr Diab Rep. 2017 Jan;17(1):3. doi: 10.1007/s11892-017-0831-1.
Li M, Li Y, Weeks O, et al. SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function. J Am Soc Nephrol. 2017 Mar;28(3):981-994.
Eleftheriadou I, Grigoropoulou P, Kokkinos A, Mourouzis I, Perrea D, Katsilambros N, Sfikakis PP, Tentolouris N. Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus. J Diabetes Complications. 2017 Mar;31(3):599-604.
Karatzi K, Aissopou EK, Katsana K, Moiragia M, Tentolouris N, Sfikakis PP, Protogerou AD. Retinal microcirculation in association with caffeinated and alcoholic drinks in subjects at increased cardiovascular risk. Microcirculation. 2016 Oct;23(7):591-596.
Kontodimopoulos N, Veniou A, Tentolouris N, Niakas D. Validity and reliability of the Greek version of the Diabetic Foot Ulcer Scale – Short Form (DFS-SF). Hormones (Athens). 2016 Jul;15(3):394-403.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016 Jul 28;375(4):311-22.
Lingvay I, Manghi FP, García-Hernández P, Norwood P, Lehmann L, Tarp-Johansen MJ, Buse JB; DUAL V Investigators. Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial. JAMA. 2016 Mar 1;315(9):898-907. doi: 10.1001/jama.2016.1252.
Papanas N, Demetzos C, Pippa N, Maltezos E, Tentolouris N. Efficacy of a New Heparan Sulfate Mimetic Dressing in the Healing of Foot and Lower Extremity Ulcerations in Type 2 Diabetes: A Case Series. Int J Low Extrem Wounds. 2016 Mar;15(1):63-7.
Yanni AE, Stamataki N, Stoupaki M, Konstantopoulos P, Pateras I, Tentolouris N, Perrea D, T Karathanos V. Cr-enriched yeast: beyond fibers for the management of postprandial glycemic response to bread. Eur J Nutr. 2017 Jun;56(4):1445-1453.
Dimitriadis K, Tsioufis C, Mazaraki A, Liatakis I, Koutra E, Kordalis A, Kasiakogias A, Flessas D, Tentolouris N, Tousoulis D. Waist circumference compared with other obesity parameters as determinants of coronary artery disease in essential hypertension: a 6-year follow-up study. Hypertens Res. 2016 Jun;39(6):475-9.
Aissopou EK, Papathanassiou M, Nasothimiou EG, Konstantonis GD, Tentolouris N, Theodossiadis PG, Papaioannou TG, Sfikakis PP, Protogerou AD. The Keith-Wagener-Barker and Mitchell-Wong grading systems for hypertensive retinopathy: association with target organ damage in individuals below 55 years. J Hypertens. 2015 Nov;33(11):2303-9.
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015 Nov 26;373(22):2117-28.
Aissopou EK, Argyris AA, Nasothimiou EG, Konstantonis GD, Tampakis K, Tentolouris N, Papathanassiou M, Theodossiadis PG, Papaioannou TG, Stehouwer CD, Sfikakis PP, Protogerou AD. Ambulatory Aortic Stiffness Is Associated With Narrow Retinal Arteriolar Caliber in Hypertensives: The SAFAR Study. Am J Hypertens. 2015 Aug 24. pii: hpv145.
Antonopoulos AS, Siasos G, Konsola T, Oikonomou E, Tentolouris N, Kollia C, Gouliopoulos N, Zografos T, Papavassiliou AG, Tousoulis D. Arterial Wall Elastic Properties and Endothelial Dysfunction in the Diabetic Foot Syndrome in Patients With Type 2 Diabetes. Diabetes Care. 2015 Nov;38(11):e180-1. doi: 10.2337/dc15-1042.
Protogerou AD, Fransen J, Zampeli E, Argyris AA, Aissopou E, Arida A, Konstantonis GD, Tentolouris N, Makrilakis K, Psichogiou M, Daikos G, Kitas GD, Sfikakis PP. The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus. PLoS One. 2015 Jul 31;10(7):e0132307. doi: 10.1371/journal.pone.0132307.
Migdalis I, Rombopoulos G, Hatzikou M, Manes C, Kypraios N, Tentolouris N. The Cost of Managing Type 2 Diabetes Mellitus in Greece: A Retrospective Analysis of 10-Year Patient Level Data “The HERCULES Study”. Int J Endocrinol. 2015;2015:520759. doi: 10.1155/2015/520759.
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. The GOMAP Investigators. Nat Commun. 2015 Jan 29;6:5897. doi: 10.1038/ncomms6897.
Argiana V, Kanellos PΤ, Makrilakis K, Eleftheriadou I, Tsitsinakis G, Kokkinos A, Perrea D, Tentolouris N. The effect of consumption of low-glycemic-index and low-glycemic-load desserts on anthropometric parameters and inflammatory markers in patients with type 2 diabetes mellitus. Eur J Nutr. 2015 Oct;54(7):1173-80. doi: 10.1007/s00394-014-0795-8.